RX 821002 hydrochloride

CAS No. 109544-45-8

RX 821002 hydrochloride ( —— )

Catalog No. M22727 CAS No. 109544-45-8

RX 821002 hydrochloride?is a selective α2-adrenoceptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 58 In Stock
25MG 110 In Stock
50MG 200 In Stock
100MG 320 In Stock
200MG 474 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RX 821002 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    RX 821002 hydrochloride?is a selective α2-adrenoceptor antagonist.
  • Description
    RX 821002 hydrochloride?is a selective α2-adrenoceptor antagonist.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    Adrenergic Receptor
  • Recptor
    α2-adrenoceptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    109544-45-8
  • Formula Weight
    270.72
  • Molecular Formula
    C12H14N2O3·HCl
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.COC1(COc2ccccc2O1)C1=NCCN1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Clarke R W , Harris J . RX 821002 as a tool for physiological investigation of alpha(2)-adrenoceptors.[J]. C N S Drug Reviews, 2002, 8(2):177-192.
molnova catalog
related products
  • 2,4'-Dihydroxybenzop...

    2,4-dihydroxybenzophenone (BP-1) can effectively protect C57BL/6J mice from APAP-induced hepatotoxicity.

  • Amezinium (methylsul...

    Amezinium metilsulfate has multiple mechanisms including stimulation of alpha and beta-1 receptors and inhibition of noradrenaline and tyramine uptake.

  • Olodaterol

    A potent, selective long-acting β2 adrenoceptor agonist with EC50 of 1.4 nM for hβ2; shows >250 fold selectivity over hβ1; exerts a bronchodilatory efficacy over 24 h in dogs and guinea pigs in the absence of systemic pharmacodynamic effects.COPDPhase 3 Clinical